Royalty Pharma plc 5.2% 25-SEP-2035 risks and ratings
Below, we've gathered key metrics for RPHC6166014 risk analysis: see the bond security level, means of inflation protection, issuer rating, and more to evaluate how reliable the RPHC6166014 bonds are and make an informed decision.
See what analysts are saying
Gain access to exclusive analysts ratings for bonds including risks, ratings, and more.
